Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation

Journal of Neuroscience Research

Volumn 85, Issue 5, 2007, Pages 1065-1076

  Zhao, Hongru ^a,b   Zhu, Wen ^a   Pan, Tianhong ^a   Xie, Wenjie ^a   Zhang, Aijun ^a   Ondo, William G ^a   Le, Weidong ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

DA receptor; Locomotor activity; Restless legs syndrome; Spinal cord

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; MESSENGER RNA; OXIDOPAMINE; RADIOLIGAND; ROPINIROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HEMOGLOBIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IRON DEFICIENCY; IRON DEPLETION; IRON STORAGE; LOCOMOTION; LUMBAR SPINAL CORD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SPINAL CORD LESION;

ANIMALS; BINDING, COMPETITIVE; CIRCADIAN RHYTHM; DENERVATION; DISEASE MODELS, ANIMAL; DOPAMINE; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; EFFERENT PATHWAYS; FOOD, FORMULATED; IRON; IRON, DIETARY; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURONS; NEUROTOXINS; OXIDOPAMINE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE; RESTLESS LEGS SYNDROME; RNA, MESSENGER; SPINAL CORD;

EID: 34147212105     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21207     Document Type: Article

References (45)

1. Abrahamson EE, Moore RY. 2001. Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res 916:172-191.
2. Accolé D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH, Gauda EB, Lee EJ, Cool MH, Sibley DR, Gerfen CR, Westphal H, Fuchs S. 1996. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci U S A 93: 1945-1949.
3. Allen RP, Earley CJ. 2001. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18:128-147.
4. Asico LD, Ladines C, Fuchs S, Accili D, Carey RM, Semeraro C, Pocchiari F, Felder RA, Eisner GM, Jose PA. 1998. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest 102:493-498.
5. Aubert I, Guigoni C, Hakansson K, Li Q, Dovero S, Barthe B, Bernard H, Bioulac , Gross CE, Fisone G, Bloch B, Bezard E. 2005. Increase D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57:17-26.
6. Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. 2000. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 54:1609-1616.
7. Barriere G, Mellen N, Cazalets J. 2004. Neuromodulation of the locomotor network by dopamine in the isolated spinal cord of newborn rat. J Neurophysiol 19:1325-1335.
8. Ben-Shachar D, Finberg JP, Youdim MB. 1985. Effect of iron chelators on dopamine D2 receptors. J Neurochem 45:999-1005.
9. Clemens S, Hochman S. 2004. Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice. J Neurosci 4:11337-11345.
10. Clemens S, Rye D, Hochman S. 2006. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67:125-130.
11. Connor JR, Boyer PJ, Menzies BS, Dellinger B, Allen RP, Ondo WG, Earley CJ. 2003. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61:304-309.
12. Earley CJ, Hyland K, Allen RP. 2001. CSF dopamines, serotonin, and biopterin metabolites in patients with restless legs syndrome. Mov Disord 16:144-149.
13. Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. 2001. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav 69:409-418.
14. Gao X, Zhang YQ, Zhang LM, Wu G. 2001. Effects of dopaminergic agents on earrageenan hyperalgesia after intrathecal administration to rats. Eur J Pharmacol 418:73-77.
15. Garraway SM, Hochman S. 2001. Modulatory actions of serotonin, norepinephrine, dopamine, and acetylcholine in spinal cord deep dorsal horn neurons. J Neurophysiol 86:2183-2194.
16. Gladwell SJ, Coote JH. 1999a. Fast excitatory postsynaptic potentials and their response to catecholaminergic antagonists in rat sympathetic preganglionic neurons in vitro. Neurosci Lett 268:89-92.
17. Gladwell SJ, Coote JH. 1999b. Inhibitory and indirect excitatory effects of dopamine on sympathetic preganglionic neurons in the neonatal rat spinal cord in vitro. Brain Res 818:397-407.
18. Hening WA. 2002. Restless legs syndrome: a sensorimotor disorder of sleep/wake motor regulation. Curr Neurol Neurosci Rep 2:186-196.
19. Jiang CT, Wan XH, He Y, Pan TH, Jankovic J, Le WD. 2005. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol 191:154-162.
20. Klein T, Magerl W, Hopf HC, Sandkuhler J, Treede RD. 2004. Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans. J Neurosci 24:964-971.
21. Stiasny-Kolster K, Moller JC, Zschocke J, Bandmann O, Cassel W, Oertel WH, Hoffmann GF. 2004. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Mov Disord 19:192-196.
22. LeSauter J, Silver R. 1998. Output signals of the SCN. Chronobiol Int 15:535-500.
23. Levant B, McCarson KE. 2001. D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function. Neurosci Lett 303: 9-12.
24. Moore RY. 1996. Entrainment pathways and the functional organization of the circadian system. Prog Brain Res 111:103-119.
25. Nakamura T, Honda M, Kimura S, Tanabe M, Oda S, Ono H. 2005. Taltirelin improve motor ataxia independently of monoamine levels in rolling mouse Nagoya, a model of spinocerebellar atrophy. Biol Pharm Bull 28:2244-2247.
26. Nofzinger EA, Fasiczka A, Berman S, Thase ME. 2000. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry 61:858-862.
27. Ondo WG, He Y, Rajasekaran S, Le WD. 2000. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 15:154-158.
28. Peyron C, Luppi PH, Kitahama K, Fort P, Hermann DM, Jouvet M. 1995. Origin of the dopaminergic innervation of the rat dorsal raphe nucleus. Neuroreport 6:2527-2531.
29. Picchietti D, Winkelman JW. 2005. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 28:891-898.
30. Pivonello R, Ferone D, de Herder WW, de Krijger RR, Waaijers M, Mooij DM, van Koetsveld PM, Barreca A, De Caro ML, Lombardi G, Colao A, Lamberts SW, Hofland LJ. 2004. Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors. J Clin Endocr Metab 89:4493-4502.
31. Qu S, Ondo WG, Zhang X, Pan TH, Xie WJ, Le WD. 2006. Projections of diencephalic dopamine neurons into the spinal cord in mice. Exp Brain Res 168:152-156.
32. Qu S, Le WD, Zhang X, Xie WJ, Ondo WG. 2007. Animal model for restless legs syndrome: A11 dopaminergic lesioning and iron deprivation. J Neuropath Exp Neurol (in press).
33. Robinson SE, Austin MJ, Gibbens DM. 1985. The role of serotonergic neurons in dorsal raphe, median raphe and anterior hypothalamic pressor mechanisms. Neuropharmacology 24:51-58.
34. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. 2000. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 54:1064-1068.
35. Skagerberg G, Lindvall O. Organization of diencephalic dopamine neurons projecting to the spinal cord in the rat. 1985. Brain Res 342: 340-351.
36. Tamae A, Nakatsuka T, Koga K, Kato G, Furue H, Katafuchi T, Yoshimura M. 2005. Direct inhibition of substantia gelatinosa neurons in the rat spinal cord by activation of dopamine D2-like receptors. J Physiol 568:243-253.
37. Trenkwalder C, Walters AS, Hening WA, Chokroverty S, Antonini A, Dhawan V, Eidelberg D. 1999. Positron emission tomographic studies in restless legs syndrome. Mov Disord 14:141-145.
38. Tribl GG, Asenbaum S, Happe S, Bonelli RM, Zeitlhofer J, Auff E. 2004. Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep. Nucl Med Commun 25:55-60.
39. Turjanski N, Lees AJ, Brooks DJ. 1999. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 52:932-937.
40. Ulfberg J, Nystrom B, Carter N, Edling C. 2001. Restless legs syndrome among working-aged women. Eur Neurol 46:17-19.
41. van Dijken H, Buijs RM, Goedkengt H, Gosens T, Bongers CM. 1996a. Distribution of dopamine immunoreactivity in the rat, cat and monkey spinal cord. J Comp Neurol 376:631-652.
42. van Dijken H, Dijk J, Voom P, Holstege JC. 1996b. Localization of dopamine D2 receptor in rat spinal cord identified with immunocytochemistry and in situ hybridization. Eur J Neurosci 8:621-628.
43. Venugopalan VV, Ghali Z, Senecal J, Reader TA, Descarries L. 2006. Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter. Brain Res 1070:90-100.
44. Yang HW, Zhou LJ, Hu NW, Xin WJ, Liu XG. 2005. Activation of spinal cord D1/D5 receptors induces late-phase LTP of C-fibre-evoked field potentials in rat spinal dorsal horn. J Neurophysiol 94:961-967.
45. Youdim MB, Ashkenazi R, Ben-Shachar D, Yehuda S. 1984. Modulation of dopamine receptor in the striatum by iron: behavioral and biochemical correlates. Adv Neurol 40:159-170.